Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Spondylolisthesis

Essential points for quick revision.

Saved on this device
!
Acute neural compromise in a patient with vertebral slip

Spondylolisthesis is often stable, but new cauda equina symptoms, rapidly progressive weakness, major trauma or destructive disease may signal acute compression or instability rather than uncomplicated mechanical pain.

Action: Use the appropriate immediate cauda equina, trauma or malignant/infective compression pathway; protect the spine when trauma or gross instability is possible and obtain urgent specialist imaging.

Synopsis

Classify vertebral slip by cause and age, recognise instability and neural compromise, choose appropriate standing and cross-sectional imaging, and separate adult degenerative from adolescent pars-related pathways.

  • Spondylolisthesis is translation of one vertebra relative to another. Degenerative slip usually affects older adults at L4–5 with intact pars; isthmic slip follows a pars defect, often at L5–S1 and may arise during growth.
  • A slip can be incidental or cause extension-related back pain, radiculopathy, neurogenic claudication or deformity. Symptoms and neurological findings—not grade alone—set clinical urgency.
  • Keep age-specific pathways separate: an adolescent athlete with pars stress injury is not managed by an adult degenerative-stenosis algorithm, and the adult NASS isthmic guideline explicitly excludes paediatric patients.

Key red flags

New bladder, bowel or sexual dysfunction or saddle numbness with severe radiating low-back pain requires immediate cauda equina assessment.

Rapidly progressive motor deficit, bilateral weakness or loss of walking needs urgent spinal review and imaging.

High-energy trauma, marked deformity or severe pain with neurological change raises unstable injury; apply a trauma pathway rather than assuming chronic slip.

Fever, immune compromise, cancer history, weight loss or destructive imaging features suggest infection or malignancy as the cause of instability.

A growing child or adolescent with progressive slip, neurological deficit, marked hamstring tightness or abnormal posture needs paediatric spinal specialist review.

Upper-motor-neuron signs or a sensory level cannot be explained by an isolated lumbar slip and require cord localisation.

Paediatric progression risk

Growth remaining, higher-grade slip, abnormal posture, hamstring spasm, neurological symptoms or documented progression warrant paediatric spinal specialist assessment.

Acute cauda equina or motor decline

New sacral dysfunction or rapidly progressive weakness requires emergency evaluation independently of the known chronic slip.

Investigation priorities

01
Standing anteroposterior and lateral lumbar radiographsFirst step

Confirm translation under load, identify level, estimate Meyerding grade and assess alignment.

Management branches

Adult symptomatic-slip pathwayStable adult degenerative or isthmic spondylolisthesis

An adult has concordant mechanical, radicular or claudicant symptoms without emergency neurological compromise.

  1. Classify the slip and clinical syndrome, explain that radiographic grade alone does not mandate surgery, and begin diagnosis-specific activity, exercise and functional rehabilitation with medicine-risk review.
  2. If disabling symptoms persist, obtain standing and management-changing cross-sectional imaging and refer for specialist correlation of neural compression, dynamic instability, deformity, comorbidity and goals.

Key medicines

Oral NSAIDFor an appropriate adult, use the selected product at the lowest effective dose for the shortest necessary period.Assess gastrointestinal, renal, hepatic and cardiovascular risks, pregnancy and interactions; consider gastroprotection and monitoring. Paediatric prescribing requires an age-appropriate product and clinician and is not inferred from adult NG59.
Opioid or sedating neuropathic medicineAvoid automatic chronic escalation; if already used, review indication, measurable benefit, adverse effects and withdrawal needs.Sedation, falls, impaired driving, constipation and dependence may be especially harmful. Follow the applicable indication-specific guidance rather than extrapolating a dose across adult and paediatric populations.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 13 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom